You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
X Demographics
Mendeley readers
Attention Score in Context
Title |
Progesterone receptor positivity is a predictor of long-term benefit from adjuvant tamoxifen treatment of estrogen receptor positive breast cancer
|
---|---|
Published in |
Breast Cancer Research and Treatment, October 2016
|
DOI | 10.1007/s10549-016-4007-5 |
Pubmed ID | |
Authors |
Anna Nordenskjöld, Helena Fohlin, Tommy Fornander, Britta Löfdahl, Lambert Skoog, Olle Stål |
X Demographics
The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 2 | 67% |
Unknown | 1 | 33% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 2 | 67% |
Practitioners (doctors, other healthcare professionals) | 1 | 33% |
Mendeley readers
The data shown below were compiled from readership statistics for 56 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
United Kingdom | 1 | 2% |
Unknown | 55 | 98% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Student > Ph. D. Student | 6 | 11% |
Student > Bachelor | 6 | 11% |
Student > Postgraduate | 5 | 9% |
Other | 4 | 7% |
Student > Master | 4 | 7% |
Other | 12 | 21% |
Unknown | 19 | 34% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 20 | 36% |
Biochemistry, Genetics and Molecular Biology | 6 | 11% |
Pharmacology, Toxicology and Pharmaceutical Science | 2 | 4% |
Unspecified | 2 | 4% |
Agricultural and Biological Sciences | 2 | 4% |
Other | 4 | 7% |
Unknown | 20 | 36% |
Attention Score in Context
This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 19 October 2016.
All research outputs
#16,443,300
of 25,837,817 outputs
Outputs from Breast Cancer Research and Treatment
#3,472
of 5,058 outputs
Outputs of similar age
#195,960
of 330,579 outputs
Outputs of similar age from Breast Cancer Research and Treatment
#35
of 78 outputs
Altmetric has tracked 25,837,817 research outputs across all sources so far. This one is in the 34th percentile – i.e., 34% of other outputs scored the same or lower than it.
So far Altmetric has tracked 5,058 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 7.4. This one is in the 29th percentile – i.e., 29% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 330,579 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 38th percentile – i.e., 38% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 78 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 53% of its contemporaries.